Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Gonadorelin structure

Gonadorelin

Other
Approved Research
85%
Low Risk
1/5

Warnings

Continuous use causes receptor downregulation
Use pulsatile dosing to maintain effect

Contraindications

PregnancyHormone Dependent Tumors

Possible Side Effects

HeadacheFlushingNauseaInjection Site Reactions

Legal & Regulatory

FDA Status FDA Approved
WADA Status Prohibited in Sport
Approved In USA, EU
Prescription Required

Pregnancy

Category X - Contraindicated